company background image
B7Y logo

Byotrol DB:B7Y Stock Report

Last Price

€0.0005

Market Cap

€2.1m

7D

0%

1Y

-93.3%

Updated

21 Mar, 2024

Data

Company Financials +

B7Y Stock Overview

Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally.

B7Y fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Byotrol plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Byotrol
Historical stock prices
Current Share PriceUK£0.0005
52 Week HighUK£0.019
52 Week LowUK£0.0005
Beta-0.40
1 Month Change0%
3 Month Change0%
1 Year Change-93.33%
3 Year Change-99.17%
5 Year Change-97.50%
Change since IPO-98.39%

Recent News & Updates

Recent updates

Shareholder Returns

B7YDE ChemicalsDE Market
7D0%3.4%0.07%
1Y-93.3%5.0%4.9%

Return vs Industry: B7Y underperformed the German Chemicals industry which returned 5% over the past year.

Return vs Market: B7Y underperformed the German Market which returned 4.9% over the past year.

Price Volatility

Is B7Y's price volatile compared to industry and market?
B7Y volatility
B7Y Average Weekly Movement374.3%
Chemicals Industry Average Movement4.4%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.5%

Stable Share Price: B7Y's share price has been volatile over the past 3 months.

Volatility Over Time: B7Y's weekly volatility has increased from 243% to 374% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200536David Traynorhttps://byotrolplc.com

Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. The company operates through Professional and Consumer segments. Its product portfolio includes Actizone, a antimicrobial technology which improves cleaning performance and long-lasting protection against bacteria; and Byotrol, a long-lasting antimicrobial protection for various applications including bathroom cleaners to multi-surface wipes.

Byotrol plc Fundamentals Summary

How do Byotrol's earnings and revenue compare to its market cap?
B7Y fundamental statistics
Market cap€2.12m
Earnings (TTM)-€2.16m
Revenue (TTM)€5.11m

0.4x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
B7Y income statement (TTM)
RevenueUK£4.38m
Cost of RevenueUK£2.52m
Gross ProfitUK£1.86m
Other ExpensesUK£3.72m
Earnings-UK£1.85m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0041
Gross Margin42.51%
Net Profit Margin-42.33%
Debt/Equity Ratio19.7%

How did B7Y perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.